Taking the industry pulse following BIO-Europe

BIO-Europe is one of the last big industry conferences in the calendar, and is a useful bellwether for the year ahead.

What’s getting attention from investors? Are there still big deals to be done before year end? And what’s keeping biopharma executives awake at night?

Share:

Watch now








About this webinar

In this Evaluate webinar, industry experts Daniel Chancellor and Melanie Senior revisited the hot topics from BIO Europe, and discussed what they might mean for the coming year.

Get insights on:

  • The key topics at BIO-Europe – from the panels, presentations and the show floor
  • The appetite for deal-making ahead of the important Jefferies and JP Morgan investor conferences
  • How the industry is feeling about external pressures like the IRA, BIOSECURE Act and a new Trump administration.

Daniel and Melanie were both on the ground in Stockholm and have brought in anecdotes from their panel discussions and interviews, covering the key themes that came up throughout the event.

View the discussion to make sure your finger is firmly on the pulse heading into 2025.

Speakers

Evaluate-Author-Daniel-Chancellor

Dan Chancellor

VP Norstella Thought Leadership
Melanie Senior

Melanie Senior

Healthcare Writer and Analyst

Explore all webinars